US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader - Combination drug - Document - PDFSEARCH.IO

First Page	Meta Content
	US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team Leader Add to Reading List Open Document File Size: 1.004,46 KB Share Result on Facebook Company Glaxosmithkline plc / / Event FDA Phase / / IndustryTerm combination product / combination products / / MedicalCondition chronic obstructive pulmonary disease / COPD / Asthma / / Organization Pulmonary / Allergy / and Rheumatology Products Office / New Drugs Center for Drug Evaluation / US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee / Division of Pulmonary / US Food and Drug Administration / / Person Susan Limb / / Position Clinical Team Leader / / Product Fluticasone propionate / Advair Diskus / Symbicort / Discuss / / SocialTag GlaxoSmithKline Glucocorticoids Organofluorides Combination drugs Fluticasone/salmeterol Budesonide/formoterol Formoterol Chronic obstructive pulmonary disease Salmeterol Pulmonology

US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee Meeting April 17, 2013 Susan Limb, MD Clinical Team LeaderAdd to Reading List